BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30021359)

  • 1. LncRNA MEG3 enhances
    Liu Y; Yue P; Zhou T; Zhang F; Wang H; Chen X
    Biomed Pharmacother; 2018 Sep; 105():1232-1239. PubMed ID: 30021359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
    Liu Z; Chen JY; Zhong Y; Xie L; Li JS
    Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p.
    Long J; Pi X
    Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
    Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
    Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
    Zhou X; Ji G; Ke X; Gu H; Jin W; Zhang G
    Dig Dis Sci; 2015 Nov; 60(11):3271-82. PubMed ID: 26233544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA CASC2 Enhances
    Tao L; Tian P; Yang L; Guo X
    Biomed Res Int; 2020; 2020():7183629. PubMed ID: 33134385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA BISPR promotes the progression of thyroid papillary carcinoma by regulating miR-21-5p.
    Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N
    Int J Immunopathol Pharmacol; 2018; 32():2058738418772652. PubMed ID: 29856242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silence of MEG3 intensifies lipopolysaccharide-stimulated damage of human lung cells through modulating miR-4262.
    Li X; Zhang Q; Yang Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2369-2378. PubMed ID: 31184231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
    Ji L; Li X
    J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEG3 Suppresses Human Pancreatic Neuroendocrine Tumor Cells Growth and Metastasis by Down-Regulation of Mir-183.
    Zhang YY; Feng HM
    Cell Physiol Biochem; 2017; 44(1):345-356. PubMed ID: 29132136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
    Wang L; Yu M; Zhao S
    J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
    Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
    Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of lncRNA MEG3 inhibits viability, migration, and invasion and promotes apoptosis by sponging miR-127 in osteosarcoma cell.
    Wang Y; Kong D
    J Cell Biochem; 2018 Jan; 119(1):669-679. PubMed ID: 28636101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
    Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F
    Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GAS5 sponges miR-362-5p to promote sensitivity of thyroid cancer cells to
    Li L; Lin X; Xu P; Jiao Y; Fu P
    IUBMB Life; 2020 Nov; 72(11):2420-2431. PubMed ID: 32856394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a.
    Hu X; Jiang H; Jiang X
    Cancer Biol Ther; 2017 May; 18(5):331-338. PubMed ID: 28402230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.
    Tan J; Xiang L; Xu G
    IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line.
    Yang T; Zhai H; Yan R; Zhou Z; Gao L; Wang L
    Braz J Med Biol Res; 2018; 51(6):e7046. PubMed ID: 29791590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21.
    Li Z; Yang L; Liu X; Nie Z; Luo J
    Biomed Pharmacother; 2018 Aug; 104():181-192. PubMed ID: 29772439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
    Chen J; Zhao D; Meng Q
    Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.